New Directions in the Pharmacotherapy of Posttraumatic Stress Disorder

Overview

Journal Psychiatr Q

Specialty Psychiatry

Date 2002 Nov 7

PMID 12418356

Citations 3

Authors

Charles R Marmar

Thomas C Neylan

Frank B Schoenfeld

Affiliations

Soon will be listed here.

Abstract

Advances in psychopharmacology of PTSD are presented, focusing on antidepressants, adrenergic agents, antianxiety agents, and mood stabilizers. Treatment recommendations are related to recent advances in the understanding of the biology of PTSD. Pharmacotherapy of PTSD in children and adolescents is discussed, including recommended dose ranges. Recommendations are specified for pharmacotherapy of trauma survivors in the immediate aftermath of traumatic exposure, and for those with acute and chronic posttraumatic stress disorders.

Citing Articles

Posttraumatic stress disorder in children and adolescents: a review of psychopharmacological treatment.

Huemer J, Erhart F, Steiner H Child Psychiatry Hum Dev. 2010; 41(6):624-40.

PMID: 20567898 DOI: 10.1007/s10578-010-0192-3.

Brief report: Utility of a short screening scale for DSM-IV PTSD in primary care.

Kimerling R, Ouimette P, Prins A, Nisco P, Lawler C, Cronkite R J Gen Intern Med. 2006; 21(1):65-7.

PMID: 16423126 PMC: 1484617. DOI: 10.1111/j.1525-1497.2005.00292.x.

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Asnis G, Kohn S, Henderson M, Brown N Drugs. 2004; 64(4):383-404.

PMID: 14969574 DOI: 10.2165/00003495-200464040-00004.

References

Gupta S, Austin R, Cali L, Bhatara V . Nightmares treated with cyproheptadine. J Am Acad Child Adolesc Psychiatry. 1998; 37(6):570-2. DOI: 10.1097/00004583-199806000-00003. View

Rapaport M, Endicott J, Clary C . Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry. 2002; 63(1):59-65. DOI: 10.4088/jcp.v63n0112. View

Duffy J, Malloy P . Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial. Ann Clin Psychiatry. 1994; 6(1):33-7. DOI: 10.3109/10401239409148837. View

Davidson J, Pearlstein T, Londborg P, Brady K, Rothbaum B, Bell J . Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry. 2001; 158(12):1974-81. DOI: 10.1176/appi.ajp.158.12.1974. View

Hamner M, Brodrick P, Labbate L . Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry. 2002; 13(3):141-6. DOI: 10.1023/a:1012281424057. View

Raskind M, Dobie D, Kanter E, Petrie E, Thompson C, Peskind E . The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J Clin Psychiatry. 2000; 61(2):129-33. DOI: 10.4088/jcp.v61n0208. View

Neylan T, Metzler T, Schoenfeld F, Weiss D, Lenoci M, Best S . Fluvoxamine and sleep disturbances in posttraumatic stress disorder. J Trauma Stress. 2001; 14(3):461-7. DOI: 10.1023/A:1011100420978. View

Rijnders R, Laman D, Van Diujn H . Cyproheptadine for posttraumatic nightmares. Am J Psychiatry. 2000; 157(9):1524-5. DOI: 10.1176/appi.ajp.157.9.1524-a. View

Robert R, Blakeney P, Villarreal C, Rosenberg L, Meyer 3rd W . Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J Am Acad Child Adolesc Psychiatry. 1999; 38(7):873-82. DOI: 10.1097/00004583-199907000-00018. View

10.

Southwick S, Paige S, Morgan 3rd C, Bremner J, Krystal J, Charney D . Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry. 1999; 4(4):242-8. DOI: 10.153/SCNP00400242. View

11.

Gillin J, Schnierow B, Rapaport M, Kelsoe J, Raimo E, Marler M . An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. J Clin Psychiatry. 2002; 62(10):789-96. DOI: 10.4088/jcp.v62n1007. View

12.

Harmon R, Riggs P . Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996; 35(9):1247-9. DOI: 10.1097/00004583-199609000-00022. View

13.

Looff D, Grimley P, Kuller F, Martin A, Shonfield L . Carbamazepine for PTSD. J Am Acad Child Adolesc Psychiatry. 1995; 34(6):703-4. DOI: 10.1097/00004583-199506000-00008. View

14.

Berlant J, van Kammen D . Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry. 2002; 63(1):15-20. DOI: 10.4088/jcp.v63n0104. View

15.

Donnelly C, March J . Psychopharmacology of pediatric posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 1999; 9(3):203-20. DOI: 10.1089/cap.1999.9.203. View

16.

Keck Jr P, McElroy S, Friedman L . Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol. 1992; 12(1 Suppl):36S-41S. DOI: 10.1097/00004714-199202001-00006. View

17.

Marshall R, Beebe K, Oldham M, Zaninelli R . Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001; 158(12):1982-8. DOI: 10.1176/appi.ajp.158.12.1982. View

18.

Pitman R, Sanders K, Zusman R, Healy A, Cheema F, Lasko N . Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002; 51(2):189-92. DOI: 10.1016/s0006-3223(01)01279-3. View

19.

Cahill L, Prins B, Weber M, McGaugh J . Beta-adrenergic activation and memory for emotional events. Nature. 1994; 371(6499):702-4. DOI: 10.1038/371702a0. View

20.

Davis L, Nugent A, Murray J, Kramer G, Petty F . Nefazodone treatment for chronic posttraumatic stress disorder: an open trial. J Clin Psychopharmacol. 2000; 20(2):159-64. DOI: 10.1097/00004714-200004000-00007. View